Beijing Konruns Pharmaceutical Co., Ltd.

Quick facts

Phase 3 pipeline

• Jincaopian Tablets · Immunology / Respiratory
  Jincaopian Tablets is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to treat respiratory and immune-related conditions.
• KC1036 · Oncology
  KC1036 is a small molecule inhibitor targeting a specific kinase involved in cancer cell proliferation and survival.

Phase 2 pipeline

• Jincaopian Tablets high dose
• Jincaopian Tablets low dose

Phase 1 pipeline

• CX1003
• Kanitinib · Other
• KC1086

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Beijing Konruns Pharmaceutical Co., Ltd. portfolio CI brief
• Beijing Konruns Pharmaceutical Co., Ltd. pipeline updates RSS